Telix Pharmaceuticals (T3X.F) Q1 2023 Earnings

27FebConfirmed
Q3 2021
Q1 2022
Q3 2022
Q1 2023
-0.16
-0.12
-0.07
-0.03

Details

Expected EPS
-0.031762723289518034
Actual EPS
-0.06352544657903607
Surprise EPS
-0.03
Surprise Percent
+100%

Description

Telix Pharmaceuticals (T3X.F) has reported earnings of -0.06352544657903607 per share for Q1 2023.

0 Comments

Share your thoughts